Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Elena Galfetti"'
Autor:
Andrea Ruberti, Johanna A. Kremer Hovinga, Federico Nappi, Aurora Vettese, Elena Bianchi, Eliana Fernandes, Elena Galfetti, Rita Monotti, Pamella Paul, Stefano Regazzoni, Daniela Valente, Davide Rossi, Georg Stussi, Bernhard Gerber
Publikováno v:
Swiss Medical Weekly, Vol 153, Iss 3 (2023)
AIMS OF THE STUDY: Acquired haemophilia A is a rare disease with an annual incidence of 1.48 per million. Based on clinical observations, we suspect a higher incidence in southern Switzerland, and aimed at providing local epidemiological data, and cl
Externí odkaz:
https://doaj.org/article/b9cd8e6b1af4463c9eb5e55afec7ae86
Publikováno v:
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-7 (2020)
Abstract Background After several decades, cisplatin continues to be an essential drug for the treatment of several tumors, however, its potential nephrotoxicity is still a clinically relevant issue. Identification of predisposing factors for renal t
Externí odkaz:
https://doaj.org/article/5bac10a54abe4a03974ca88ca0090164
Autor:
Ruberti, Andrea Alberto, Kremer Hovinga, Johanna A, Federico, Nappi, Aurora, Vettese, Elena, Bianchi, Eliana, Fernandes, Elena, Galfetti, Rita, Monotti, Pamella, Paul, Stefano, Regazzoni, Daniela, Valente, Davide, Rossi, Georg, Stussi, Bernhard, Gerber
Publikováno v:
Ruberti, Andrea Alberto; Kremer Hovinga, Johanna A; Federico, Nappi; Aurora, Vettese; Elena, Bianchi; Eliana, Fernandes; Elena, Galfetti; Rita, Monotti; Pamella, Paul; Stefano, Regazzoni; Daniela, Valente; Davide, Rossi; Georg, Stussi; Bernhard, Gerber (2023). Acquired haemophilia A in southern Switzerland from 2013 to 2019: a case series. Swiss medical weekly, 153, p. 40048. EMH Schweizerischer Ärzteverlag 10.57187/smw.2023.40048
AIMS OF THE STUDY: Acquired haemophilia A is a rare disease with an annual incidence of 1.48 per million. Based on clinical observations, we suspect a higher incidence in southern Switzerland, and aimed at providing local epidemiological data, and cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::945dcf291c02f2396cb7a6e52a667fae
Publikováno v:
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-7 (2020)
BMC Pharmacology & Toxicology
BMC Pharmacology & Toxicology
Background After several decades, cisplatin continues to be an essential drug for the treatment of several tumors, however, its potential nephrotoxicity is still a clinically relevant issue. Identification of predisposing factors for renal toxicity c